Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma

6 clinical trials · Condition

Record	Firm	Date
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer (NCT04458909)	National Cancer Institute (NCI)	2020-12-09
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932)	Case Comprehensive Cancer Center	2015-03-03
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)	National Cancer Institute (NCI)	2011-02-10
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)	National Cancer Institute (NCI)	2010-11-01
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978)	National Cancer Institute (NCI)	2007-02-01
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma (NCT00336063)	National Cancer Institute (NCI)	2006-03-03

Every clearance here is in the API, with alerts when new ones post.